Bank Hapoalim Bm Axsome Therapeutics, Inc. Transaction History

Bank Hapoalim Bm

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 Apr 26, 2021	SELL	$55.91 - $81.44 $162,977 - $237,397	-2,915 Closed	0 $0
Q2 2020 Aug 04, 2020	SELL	$49.87 - $98.69 $66,576 - $131,751	-1,335 Reduced 31.41%	2,915 $240,000
Q4 2019 Feb 03, 2020	BUY	$16.71 - $106.24 $71,017 - $451,520	4,250 New	4,250 $439,000

326

37.7M

912K

855K

Ticker AXSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,878,000
Market Cap $3.99B
Description
Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...

Get notified when there are updates to the investment portfolio of Bank Hapoalim Bm, based on Form 13F filings with the SEC.

Stay updated on Bank Hapoalim Bm with notifications on news.